Neumora

Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating

Neumora Therapeutics, Inc. (NASDAQ:NMRA) has recently gained attention as one of the best stocks under $5 with the highest upside…

Read More »